Tisento Therapeutics
Cambridge, United States· Est.
Tisento Therapeutics develops RNA-based therapeutics targeting genetic disorders and rare diseases through advanced delivery technologies.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $81M
About
Tisento Therapeutics develops RNA-based therapeutics targeting genetic disorders and rare diseases through advanced delivery technologies.
Rare DiseaseRNA TherapeuticsGenetics & Genomics
Funding History
1Total raised:$81M
Series A$81M